Target intelligence / Profile preview

Ribosome binding factor A pseudogene

Molecular classification: Pseudogene, Other

Overview

The ribosome binding factor A pseudogene (ENSG00000270583, also known as LOC100420872) is a nonfunctional segment of DNA in the human genome, annotated as a pseudogene derived from the ribosome binding factor A (RBFA) gene[1][4]. Pseudogenes arise through gene duplication and mutation; they resemble functional genes but do not encode active proteins due to disabling mutations[2][5][7]. While some pseudogenes are transcribed or may exert regulatory effects (e.g., through lncRNAs), there is no evidence of functional protein or disease relevance for this specific locus, and it is not considered a therapeutic target[8].

Other names: RBFA pseudogeneLOC100420872AL365400.1

Beyond the preview

Go deeper on Ribosome binding factor A pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosome binding factor A pseudogene.

Explore the full profile